Virginia lawmakers have introduced legislation to ban toxic chemicals used in cosmetics, adding the state to a growing list of US jurisdictions pursuing restrictions on beauty and personal care ingredients outside the federal framework.

The proposal, reported by the Virginia Mercury, signals another state-level intervention in an area formulators and compliance teams already track closely. For brands selling across the United States, each new state restriction multiplies the work: revised INCI declarations, reformulated SKUs, updated safety documentation and state-specific labeling reviews.

Why does another state ban matter?

Since the Modernization of Cosmetics Regulation Act (MoCRA) gave the FDA expanded authority over cosmetics safety, states have continued legislating independently on specific chemical classes. California, Washington and others have already adopted restrictions on ingredients used in color cosmetics, hair care and skincare.

A Virginia ban would create a new compliance boundary. Multi-state brands would need to decide between:

• Reformulating nationally to a single, strictest-state standard;
• Maintaining dual inventories, with separate SKU codes and distribution controls;
• Withdrawing affected products from the Virginia market.

Each path carries cost. Reformulation cycles typically run months, not weeks, and ingredient suppliers must be lined up for substitutes that match performance claims.

What should formulators and buyers watch?

Until the bill text specifies the chemicals in scope, cosmetics manufacturers cannot quantify exposure across their portfolios. The critical first checkpoint is the committee referral: which House or Senate committee takes the bill, and whether it survives crossover.

Procurement teams should prepare by mapping current formulations against the ingredient categories most frequently targeted in state legislation — the same classes covered by earlier state bans that industry groups have contested.

Suppliers of alternative ingredients stand to gain. Every state restriction that survives litigation historically shifts demand toward replacement chemistries, and forward-thinking formulators secure supply agreements before legislative deadlines force the whole market to move at once.

What happens next?

The bill now enters the Virginia General Assembly's committee process. The next data point to watch: the published list of restricted substances, which will determine whether this is a narrow, manageable exclusion or a broad reformulation mandate for the mid-Atlantic market.